Literature DB >> 19128377

Otago Glaucoma Surgery Outcome Study: long-term results of 841 trabeculectomies.

Tui H Bevin1, Anthony C B Molteno, Peter Herbison.   

Abstract

BACKGROUND: To describe the long-term outcomes of trabeculectomies performed at Dunedin Hospital and followed in the Otago Glaucoma Surgery Outcome Study.
METHODS: Prospective non-comparative case series of 841 eyes of 607 patients who had first trabeculectomies for primary open- or closed-angle glaucoma at Dunedin Hospital between 1976 and 2005 and followed for a mean of 7.5 years (standard deviation 6.0).
RESULTS: The probability of a trabeculectomy controlling the intraocular pressure at 21 mmHg or less at 1, 10 and 20 years was 0.96 (95% confidence interval [CI] 0.95, 0.97), 0.86 (95% CI 0.83, 0.89) and 0.79 (95% CI 0.74, 0.83), respectively. Visual acuity was maintained or improved between preoperative assessment and final follow up in 68% of cases. The probability of not being blind following trabeculectomy at 1, 10 and 20 years was 0.98 (95% CI 0.96, 0.98), 0.83 (95% CI 0.80, 0.87) and 0.70 (95% CI 0.64, 0.76), respectively. The proportion of those with glaucomatous field loss increased during follow up from 16% (44/283) at 0-5 years to 50% (10/20) for those with 21 or more years of follow up. A repeat drainage procedure was required in 65 eyes (8%) (56 Molteno implant insertions and 9 repeat trabeculectomies).
CONCLUSIONS: Intraocular pressure was well controlled by trabeculectomy; however, a steady decline in intraocular pressure control, visual acuity and visual field occurred during follow up.

Entities:  

Mesh:

Year:  2008        PMID: 19128377     DOI: 10.1111/j.1442-9071.2008.01896.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  8 in total

1.  Central visual field change after fornix-based trabeculectomy in Japanese normal-tension glaucoma patients managed under 15 mmHg.

Authors:  Kosuke Nakajima; Rei Sakata; Koji Ueda; Asahi Fujita; Takashi Fujishiro; Megumi Honjo; Shiroaki Shirato; Makoto Aihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-30       Impact factor: 3.117

2.  Change in visual acuity 12 and 24 months after transscleral ab interno glaucoma gel stent implantation with adjunctive Mitomycin C.

Authors:  Markus Lenzhofer; Clemens Strohmaier; Melchior Hohensinn; Wolfgang Hitzl; Veit Steiner; Björn Baca; Sarah Moussa; Karolina Motloch; Herbert A Reitsamer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-07       Impact factor: 3.117

3.  Clinical outcome of phacoemulsification combined with intraocular lens implantation for primary angle closure/glaucoma (PAC/PACG) with cataract.

Authors:  Yuan He; Ruixue Zhang; Chuntao Zhang; Jun Jia; Huifeng Liu; Beilei He; Zhuoya Quan; Jian Zhang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

4.  Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study.

Authors:  Antonio Maria Fea; Martina Menchini; Alessandro Rossi; Chiara Posarelli; Lorenza Malinverni; Michele Figus
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

5.  Visual improvement following glaucoma surgery: a case report.

Authors:  William S Foulsham; Lanxing Fu; Andrew J Tatham
Journal:  BMC Ophthalmol       Date:  2014-12-23       Impact factor: 2.209

Review 6.  Ahmed glaucoma valve implant: surgical technique and complications.

Authors:  Ivano Riva; Gloria Roberti; Francesco Oddone; Anastasios Gp Konstas; Luciano Quaranta
Journal:  Clin Ophthalmol       Date:  2017-02-17

7.  Long-term perimetric stabilization with a management algorithm of set target intraocular pressure in different severities of primary angle-closure glaucoma.

Authors:  Ramanjit Sihota; Jyoti Shakrawal; Ajay K Sharma; Amisha Gupta; Tanuj Dada; Veena Pandey
Journal:  Indian J Ophthalmol       Date:  2021-10       Impact factor: 1.848

8.  Stab Incision Glaucoma Surgery: A Modified Guarded Filtration Procedure for Primary Open Angle Glaucoma.

Authors:  Soosan Jacob; Michele Figus; Dhivya Ashok Kumar; Ashvin Agarwal; Amar Agarwal; Saijimol Areeckal Incy
Journal:  J Ophthalmol       Date:  2016-04-10       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.